286
Participants
Start Date
December 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Aripiprazole
Abrupt discontinuation of prior anti-psychotic med after a successful eight-day up titration of bifeprunox
Olanzapine
Abrupt discontinuation of prior anti-psychotic med after a successful eight-day up titration of bifeprunox
Risperidone
Abrupt discontinuation of prior anti-psychotic med after a successful eight-day up titration of bifeprunox
Quetiapine
Abrupt discontinuation of prior anti-psychotic med after a successful eight-day up titration of bifeprunox
Ziprasidone
Abrupt discontinuation of prior anti-psychotic med after a successful eight-day up titration of bifeprunox
Aripiprazole
Cross-tapering during which prior anti-psychotic med will be tapered off at the same time while bifeprunox is being titrated up within 8 days
Olanzapine
Cross-tapering during which prior anti-psychotic med will be tapered off at the same time while bifeprunox is being titrated up within 8 days
Risperidone
Cross-tapering during which prior anti-psychotic med will be tapered off at the same time while bifeprunox is being titrated up within 8 days
Quetiapine
Cross-tapering during which prior anti-psychotic med will be tapered off at the same time while bifeprunox is being titrated up within 8 days
Ziprasidone
Cross-tapering during which prior anti-psychotic med will be tapered off at the same time while bifeprunox is being titrated up within 8 days
Site 148, Birmingham
Site 194, Little Rock
Site 178, Anaheim
Site 167, Cerritos
Site 189, Cerritos
Site 183, Culver City
Site 140, Garden Grove
Site 162, La Palma
Site 190, Long Beach
Site 173, Oceanside
Site 175, Paramount
Site 136, Pasadena
Site 184, Sacramento
Site 152, San Diego
Site 186, San Diego
Site 133, Santa Ana
Site 171, Torrance
Site 197, Boca Raton
Site 156, Gainesville
Site 188, Hialeah
Site 193, Jacksonville
Site 154, Miami
Site 163, North Miami
Site 168, North Miami
Site 166, Orange City
Site 124, Orlando
Site 187, Tampa
Site 161, Atlanta
Site 128, Augusta
Site 122, Decatur
Site 174, Chicago
Site 164, Indianapolis
Site 172, Lake Charles
Site 182, Shreveport
Site 121, Glen Burnie
Site 159, Detroit
Site 153, Minneapolis
Site 145, Saint Charles
Site 130, St Louis
Site 141, St Louis
Site 142, Clementon
Site 180, Kenilworth
Site 129, Albuquerque
Site 131, Brooklyn
Site 181, Cedarhurst
Site 169, Jamaica
Site 195, New York
Site 147, Staten Island
Site 127, Chagrin Falls
Site 176, Cincinnati
Site 191, Oklahoma City
Site 146, Philadelphia
Site 179, Philadelphia
Site 196, Sioux Falls
Site 134, Memphis
Site 170, Memphis
Site 177, Austin
Site 185, Conroe
Site 126, Houston
Site 151, San Antonio
Site 138, Richmond
Site 198, Spokane
Site 165, Huntington
Site 302, Buenos Aires
Site 305, Buenos Aires
Site 306, Córdoba
Site 307, La Plata
Site 301, Mendoza
Site 304, Mendoza
Site 308, Mendoza
Site 303, Rosario
Site 116, Chatham
Site 117, Mississauga
Site 100, Calgary
Site 101, Claresholm
Site 110, Halifax
Site 111, Hull
Site 107, Kelowna
Site 109, Kingston
Site 115, Markham
Site 112, Medicine Hat
Site 108, Orléans
Site 106, Ottawa
Site 104, Prince Albert
Site 102, Sherbrooke
Site 114, Victoria
Site 113, Winnipeg
Site 235, Bolonska
Site 234, Jablonova
Site 216, Litoměřice
Site 233, Na Markvartce
Site 213, Olomouc
Site 214, Pilsen
Site 215, Prague
Site 217, Prague
Site 236, Rejskovo Namesti
Site 231, Paldksi Mnt
Site 229, Tartu
Site 230, Võru
Site 202, Clermont-Ferrand
Site 203, Dole
Site 201, Saint-Cyr-au-Mont-d'Or
Site 206, Balassagyarmat
Site 204, Budapest
Site 205, Budapest
Site 208, Budapest
Site 211, Budapest
Site 207, Debrecen
Site 212, Győr
Site 209, Gyula
Site 210, Pécs
Site 219, Balvi
Site 221, Jelgava
Site 218, Liepāja
Site 222, Riga
Site 220, Sigulda
Site 225, Kaunas
Site 226, Kaunas
Site 223, Klaipėda
Site 232, Šilutė
Site 224, Vilnius
Site 228, Vilnius
H. Lundbeck A/S
INDUSTRY
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Solvay Pharmaceuticals
INDUSTRY